C073-6209 for COVID-19

 C073-6209 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed C073-6209 in detail.
Nabati et al., Virtual screening based on the structure of more than 105 compounds against four key proteins of SARS-CoV-2: MPro, SRBD, RdRp, and PLpro, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.101134